• Explore /
  • Poster
  • / Success rates and clinicopathologic associations with experimental outcomes of a novel circulating tumor cell (CTC) technology in advanced colon cancer (CC) and pancreatic cancer (PC).

Success rates and clinicopathologic associations with experimental outcomes of a novel circulating tumor cell (CTC) technology in advanced colon cancer (CC) and pancreatic cancer (PC).

Abstract Poster

Authors

null

Reetu Mukherji

MedStar Georgetown University Hospital, Washington, DC;

Reetu Mukherji , Shravanthy Suguru , Jerry Xiao , Xue Geng , Hongkun Wang , Marcus Smith Noel , Aiwu Ruth He , Benjamin Adam Weinberg , John Marshall , Seema Agarwal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Translational Research

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 805)

DOI

10.1200/JCO.2023.41.4_suppl.805

Abstract #

805

Poster Bd #

M20

Abstract Disclosures

Similar Posters

First Author: Moonho Kim

First Author: Wade T. Swenson II

First Author: Vilma Pacheco-Barcia

First Author: Chetan Vakkalagadda